INVVY
Price:
$21.8455
Market Cap:
$1.18B
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was inc...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-06-09
Stock Exchange
PNK
Ticker
INVVY
According to Indivior PLC’s latest financial reports and current stock price. The company's current ROE is 4.22%. This represents a change of -97.35% compared to the average of 159.02% of the last 4 quarters.
The mean historical ROE of Indivior PLC over the last ten years is 29.24%. The current 4.22% ROE has changed -85.56% with respect to the historical average. Over the past ten years (40 quarters), INVVY's ROE was at its highest in in the September 2023 quarter at 542.54%. The ROE was at its lowest in in the December 2022 quarter at -367.99%.
Average
29.24%
Median
-3.96%
Minimum
-192.39%
Maximum
397.98%
Discovering the peaks and valleys of Indivior PLC ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 176.22%
Maximum Annual ROE = 397.98%
Minimum Annual Increase = -1426.07%
Minimum Annual ROE = -192.39%
Year | ROE | Change |
---|---|---|
2023 | 2.95% | -102.90% |
2022 | -101.49% | -200.30% |
2021 | 101.18% | -152.59% |
2020 | -192.39% | -388.98% |
2019 | 66.58% | -83.27% |
2018 | 397.98% | -1426.07% |
2017 | -30.01% | 176.22% |
The current ROE of Indivior PLC (INVVY) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
0.88%
5-year avg
-24.63%
10-year avg
29.24%
Indivior PLC’s ROE is greater than Orexo AB (publ) (-301.91%), less than Genomma Lab Internacional, S.A.B. de C.V. (22.07%), less than Hypera S.A. (14.51%), greater than Sumitomo Pharma Co., Ltd. (-97.03%), greater than Elanco Animal Health Incorporated (-20.61%), less than SIGA Technologies, Inc. (51.39%), less than Esperion Therapeutics, Inc. (26.20%), greater than Catalent, Inc. (-26.99%), less than Neurocrine Biosciences, Inc. (15.68%), less than Amphastar Pharmaceuticals, Inc. (25.42%), less than Collegium Pharmaceutical, Inc. (49.14%), greater than Ironwood Pharmaceuticals, Inc. (-2.78%), less than ANI Pharmaceuticals, Inc. (6.02%), greater than Alpha Teknova, Inc. (-38.94%), greater than Guardion Health Sciences, Inc. (-71.26%), less than Lifecore Biomedical, Inc. (17.23%), greater than Organogenesis Holdings Inc. (-2.77%), greater than Petros Pharmaceuticals, Inc. (-134.64%), less than Pacira BioSciences, Inc. (7.32%), greater than Intra-Cellular Therapies, Inc. (-9.93%), less than Alkermes plc (26.49%), less than Eagle Pharmaceuticals, Inc. (17.39%),
Company | ROE | Market cap |
---|---|---|
-301.91% | $37.21M | |
22.07% | $1.15B | |
14.51% | $2.44B | |
-97.03% | $1.71B | |
-20.61% | $6.20B | |
51.39% | $497.44M | |
26.20% | $394.41M | |
-26.99% | $10.64B | |
15.68% | $12.19B | |
25.42% | $2.47B | |
49.14% | $1.06B | |
-2.78% | $669.31M | |
6.02% | $1.19B | |
-38.94% | $370.99M | |
-71.26% | $4.35M | |
17.23% | $220.59M | |
-2.77% | $396.40M | |
-134.64% | $3.40M | |
7.32% | $765.01M | |
-9.93% | $9.15B | |
26.49% | $4.32B | |
17.39% | $9.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Indivior PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Indivior PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Indivior PLC's ROE?
How is the ROE calculated for Indivior PLC (INVVY)?
What is the highest ROE for Indivior PLC (INVVY)?
What is the 3-year average ROE for Indivior PLC (INVVY)?
What is the 5-year average ROE for Indivior PLC (INVVY)?
How does the current ROE for Indivior PLC (INVVY) compare to its historical average?